BackAcelyrin Overview

Acelyrin Total Liabilities

Latest total liabilities for SLRN: $29M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$29.27M
↓ 45.20% YoYΔ $-24.14M vs prior year quarter

Peer average

Loading

Acelyrin Total Liabilities History

Loading

Acelyrin vs. peers: Total Liabilities Comparison

Loading

Acelyrin Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Acelyrin (SLRN) FAQ

As of the most recent data (March 2025), SLRN shows a total liabilities of $29M. That compares with $53M in the prior-year period — down 45.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SLRN's total liabilities is now $29M (was $53M) — a 45.2% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Acelyrin is outperforming or lagging.

Tracking SLRN's total liabilities over time shows whether Acelyrin is scaling, shrinking, or reshaping that part of the business. The current reading is $29M That compares with $53M in the prior-year period — down 45.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Acelyrin's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $29M) with ownership activity and broader fundamentals.